Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition

AIDS Research and Human Retroviruses

Volumn 31, Issue 11, 2015, Pages 1153-1159

  Pellett Madan, Rebecca ^a   Masson, Lindi ^b,c   Tugetman, Jessica ^a   Werner, Lise ^c   Grobler, Anneke ^c   Mlisana, Koleka ^c,d,e   Lo, Yungtai ^a   Che, Denise ^f   Arnold, Kelly B ^f   Karim, Salim S Abdool ^c,d   Passmore, Jo Ann S ^b,c   Herold, Betsy C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^f Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; HUMAN BETA DEFENSIN 1; HUMAN BETA DEFENSIN 2; HUMAN NEUTROPHIL PEPTIDE 1; HUMAN NEUTROPHIL PEPTIDE 2; HUMAN NEUTROPHIL PEPTIDE 3; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BODILY SECRETIONS; CERVICOVAGINAL LAVAGE; CHLAMYDIA; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FEMALE GENITAL SYSTEM; GONORRHEA; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PRIORITY JOURNAL; SEROCONVERSION; TRICHOMONIASIS; VAGINAL LAVAGE; VIRUS LOAD; DISEASE PREDISPOSITION; HIV INFECTIONS; IMMUNOLOGY; INNATE IMMUNITY; RISK ASSESSMENT; TRANSMISSION;

ANTIMICROBIAL CATIONIC PEPTIDES; BODILY SECRETIONS; DISEASE SUSCEPTIBILITY; ESCHERICHIA COLI; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; RISK ASSESSMENT;

EID: 84946718211     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2015.0011     Document Type: Article

References (25)

1. Kalyoussef S, Nieves E, Dinerman E, et al. : Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PloS One 2012; 7(11):e49506.
2. Madan RP, Carpenter C, Fiedler T, et al. : Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents. PloS One 2012;7(7):e40415.
3. Valore EV, Wiley DJ, and Ganz T: Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006;74(10):5693-5702.
4. Ghartey JP, Smith BC, Chen Z, et al. : Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PloS One 2014;9(5):e96659.
5. Ghartey JP, Carpenter C, Gialanella P, et al. : Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy. Am J Obstet Gynecol 2012;207(4):e291-298.
6. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010;464(7286):217-223.
7. Levinson P, Kaul R, Kimani J, et al. : Levels of innate immune factors in genital fluids: Association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009;23(3):309-317.
8. Dezzutti CS, Richardson BA, Marrazzo JM, et al. : Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis 2012; 206(12):1931-1935.
9. van Loggerenberg F, Mlisana K, Williamson C, et al. : Establishing a cohort at high risk of HIV infection in South Africa: Challenges and experiences of the CAPRISA 002 acute infection study. PloS One 2008;3(4):e1954.
10. Roberts L, Passmore JA, Mlisana K, et al. : Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis 2012; 205(2):194-203.
11. Bebell LM, Passmore JA, Williamson C, et al. : Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis 2008;198(5):710-714.
12. Roberts L, Passmore JA, Williamson C, et al. : Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 2010;24(6):819-831.
13. Mlisana K, Naicker N, Werner L, et al. : Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012;206(1):6-14.
14. Lewis DA, Muller E, Steele L, et al. : Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa. Sex Transmit Dis 2012;39(11): 880-885.
15. Lau KS, Cortez-Retamozo V, Philips SR, et al. : Multi-scale in vivo systems analysis reveals the influence of immune cells on TNF-alpha-induced apoptosis in the intestinal epithelium. PLoS Biol 2012;10(9):e1001393.
16. Lau KS, Juchheim AM, Cavaliere KR, et al. : In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-alpha-induced apoptosis and proliferation by MAPKs. Sci Signal 2011;4(165):ra16.
17. Cole AM and Cole AL: Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol 2008;59(1):27-34.
18. Morrison C, Fichorova RN, Mauck C, et al. : Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr 2014;66(2):109-117.
19. Jana NK, Gray LR, and Shugars DC: Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: A role for SLPI in innate mucosal immunity. J Virol 2005;79(10):6432-6440.
20. Ghosh M, Fahey JV, Shen Z, et al. : Anti-HIV activity in cervical-vaginal secretions from HIV-positive and-negative women correlate with innate antimicrobial levels and IgG antibodies. PloS One 2010;5(6):e11366.
21. Martellini JA, Cole AL, Venkataraman N, et al. : Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 2009;23(10):3609-3618.
22. Ganz T, Selsted ME, Szklarek D, et al. : Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985;76(4):1427-1435.
23. Ju SM, Goh AR, Kwon DJ, et al. : Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/ AP-1 dependent pathways in human B cells. Mol Cells 2012;33(4):335-341.
24. Cole AM: Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol 2006;306:199-230.
25. Hiscott J, Kwon H, and Genin P: Hostile takeovers: Viral appropriation of the NF-kappaB pathway. J Clin Invest 2001;107(2):143-151.